GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,970,000 | +43.1% | 1,500,000 | 0.0% | 6.58% | +64.2% |
Q2 2022 | $12,555,000 | -54.3% | 1,500,000 | -52.6% | 4.01% | -28.7% |
Q1 2022 | $27,471,000 | -23.3% | 3,164,835 | 0.0% | 5.62% | +11.1% |
Q4 2021 | $35,794,000 | -14.2% | 3,164,835 | -4.7% | 5.06% | +8.1% |
Q3 2021 | $41,740,000 | +54.8% | 3,320,608 | 0.0% | 4.68% | +53.4% |
Q2 2021 | $26,963,000 | -12.2% | 3,320,608 | 0.0% | 3.05% | +5.1% |
Q1 2021 | $30,716,000 | -4.3% | 3,320,608 | 0.0% | 2.90% | -39.7% |
Q4 2020 | $32,110,000 | -22.1% | 3,320,608 | 0.0% | 4.82% | -56.8% |
Q3 2020 | $41,209,000 | -4.5% | 3,320,608 | 0.0% | 11.15% | -5.5% |
Q2 2020 | $43,168,000 | -0.5% | 3,320,608 | -22.3% | 11.80% | -34.3% |
Q1 2020 | $43,399,000 | -54.6% | 4,275,726 | -30.1% | 17.96% | -41.0% |
Q4 2019 | $95,645,000 | -13.1% | 6,119,345 | -6.6% | 30.44% | -10.3% |
Q3 2019 | $110,027,000 | -28.7% | 6,553,116 | -5.8% | 33.96% | -13.7% |
Q2 2019 | $154,227,000 | +2.4% | 6,953,416 | 0.0% | 39.34% | +23.5% |
Q1 2019 | $150,681,000 | – | 6,953,416 | – | 31.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |